Dopamine receptors: From structure to behavior

Trends in Neurosciences

Volumn 23, Issue 10 SUPPL., 2000, Pages

  Sealfon, Stuart C ^a   Olanow, C Warren ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR; RECEPTOR SUBTYPE;

CRYSTAL STRUCTURE; DOPAMINE BRAIN LEVEL; DRUG RECEPTOR BINDING; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033678043     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-1931(00)00025-2     Document Type: Review

References (66)

1. Basal ganglia and movement disorders: An update
2. Dopamine receptors: From structure to function
3. New insights into dopaminergic receptor function using antisense and genetically altered animals
4. Multiple receptors for dopamine
5. Cloning and expression of a rat D2 dopamine receptor cDNA
6. Preferential coupling between dopamine D2 receptors and G-proteins
7. Distribution of dopamine D2 receptor mRNA splice variants in the rat by solution hybridization/protection assay
8. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells
9. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
10. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
11. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking
12. Genetic variants of dopamine receptor D4 and psychopathology
13. Synaptic transmission in the striatum: From plasticity to neurodegeneration
14. Single striatofugal axons arborizing in both pallidal segments and in the substantia nigra in primates
15. Dopaminergic neurons intrinsic to the primate striatum
16. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons
17. Dye-coupling in the neostriatum of the rat: I. Modulation by dopamine-depleting lesions
18. Dye coupling between rat striatal neurons recorded in vivo: Compartmental organization and modulation by dopamine
19. Sequence alignment of the G-protein coupled receptor superfamily
20. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia
21. Differential signal transduction by five splice variants of the PACAP receptor
22. Selective activation of inhibitory G-protein alpha-subunits by partial agonists of the human 5-HT1A receptor
23. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus
24. Requirement of rigid-body motion of transrmembrane helices for light activation of rhodopsin
25. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F
26. Crystal structure of rhodopsin: A G protein-coupled receptor
27. Structure of rhodopsin
28. Dopamine D4/D2 receptor selectivity is determined by a divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments
29. Receptors as kissing cousins
30. Dopamine D2 receptor dimers in human and rat brain
31. A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization
32. Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity
33. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors
34. Paradoxical locomotor behavior of dopamine D1 receptor transgenie mice
35. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations
36. Behavioural assessment of mice lacking D1A dopamine receptors
37. Action sequencing is impaired in D1A-deficient mutant mice
38. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses
39. Effects of repeated amphetamine treatment on the locomotor activity of tire dopamine D1A-deficient mouse
40. Spatial learning deficit in dopamine D(1) receptor knockout mice
41. Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor
42. Striatal excitatory amino acid receptor subunit expression in the D1A-dopamine receptor-deficient mouse
43. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
44. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing up-regulation of D2 dopamine receptors
45. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice
46. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors
47. Central administration of dopamine D3 receptor antisense to rat: Effects on locomotion, dopamine release and [3H]spiperone binding
48. Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors
49. The antisense strategy applied to the study of dopamine D3 receptor functions in rat forebrain
50. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine
51. Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists
52. Preventing levodopa-induced dyskinesias
53. Patterns of gene expression and behavior induced by chronic dopamine treatments
54. Striatal G-proteins: Effects of unilateral 6-hydroxydopamine lesions
55. Increases in guanine nucleotide binding to striatal G proteins is associated with dopamine receptor supersensitivity
56. Dopamine-mediated gene regulation in models of Parkinson's disease
57. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons
58. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum
59. Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: Comparison with L-DOPA therapy
60. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists
61. Dopamine agonists and neuroprotection in Parkinson's disease
62. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2) receptors
63. Pattern of gene induction by dopamine agonists in rat midbrain cultures studied by microarray analysis
64. Functional uncoupling of linked neurotransmitter effects by combinatorial convergence
65. Emergent properties of networks of biological signaling pathways